Designing Transferable Analytical Methods
Analytical methods should never live in a vacuum. No matter how robust and consistent your assays are today, the time will come when a tech transfer, a scale-up, a supplier change, a partnership deal, or some other force of change on the biopharma landscape requires an analytical methods transfer. You should be preparing for that day.
In this Bioprocess Online Live digital event, host Tyler Menichiello welcomed Moffitt Cancer Center's Cheryl Cox, consultant William Janssen, PhD, and Bristol Myers Squibb's Stephan Krause, PhD for a discussion on ensuring that the analytical methods you're developing today (think flow cytometry, ELISA, mass spectrometry, HPLC, and more) are seamlessly transferable tomorrow.
Available on-demand thanks to the support of BD Biosciences.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.